News

Voyager Therapeutics, Inc.: Voyager Adds Fourth Wholly-Owned Alzheimer's Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach
New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager's wholly- ...
300 people in line? How hard-to-find bourbons made Buffalo Trace Distillery a cult favorite
Make no mistake, this is a cultural phenomenon for bourbon lovers. But it was also just another day at the Kentucky bourbon distillery.Start the day smarter. Get all the news you need in your inbox ...